[1]Ferenci P,Lockwood A,Mullen,K,et al. Hepatic en- cephalopathy definition, nomenclature diagnosis,and quantification: final report of the working party at the 11th World Congresses of Gastroenterology,vienna,1998[J]. Hepatology ,2002,35: 716-721 .
[2]贾林,张美华. 肝性脑病的定义、命名、诊断和定量标准
修订方案的新进展[J]. 世界华人消化杂志,2003,12 ( 10) : 2008-2010.
[3]Elliott TR,Hudspith B,Karaiskos C,et al. Prolonged survival of E coli but not Staphylococcus aureus in monocytes from patients with Crohn’s disease [J]. cut, 2011,60 ( Suppl 1) : A61-A62.
[4]Bajaj,JS. Minimal hepatic enceplialopathy matters in daily life[J]. World J Gastroenterol,2008,14 ( 23 ) : 3609 -3615.
[5]曾峥,李喻元,聂玉强. 亚临床肝性脑病的流行病学调
查[J]. 中华肝脏病杂志,2003,11( 11) : 680-682.
[6]Leevy CB,Phillips JA. Hospitalizations during the use of rifaximin Versus lactulose for the treatment of hepatic ena- ephalopathy [J]. Dig Dis Sci,2007,52( 3) : 737-741.
[7]那丼春. 肝性脑病诊断治疗专家共识[J]. 中华实验和
临床感染病杂志,2009,11( 3) : 449-447.
[8]Ampuero J,Simón M,Montoliú C,et al. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis [J ]. Gastroenterology. 2015,149( 6) : 1483-1489.
收稿日期:2016-07-18编辑:孙理军*
**
项目基金:广西高等学校高水平创新团队及卓越学者项目;国家中医药管理局“慢性重型肝炎解毒化瘀”重点研究
室,广西中医药大学青年基金(QN14010);广西中医药大学普通课题(P2012047)
通讯作者:王秀峰(1983-),女,医学硕士,研究方向:中医药防治肝衰竭及其并发症的机制研究。E-mail:Wangxiufeng2002@163.com